Related Experiment Video
Updated: Apr 30, 2026

07:24
Autologous Microfractured and Purified Adipose Tissue for Arthroscopic Management of Osteochondral Lesions of the Talus
Published on: January 23, 2018
10.3K
Transarticular versus Transosseous Amputations in Diabetic Foot Osteomyelitis: A Retrospective Comparative Study
Felix W A Waibel1, Madlaina Schöni1, Thomas V Häller1
1*Department of Orthopedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Journal of the American Podiatric Medical Association
|November 15, 2024
Summary
Transarticular and transosseous amputations for diabetic foot osteomyelitis show similar rates of clinical and microbiological failure within one year. This study suggests amputation type does not significantly impact reamputation risk in DFO patients.
Area of Science:
- Orthopedic Surgery
- Diabetic Foot Management
- Infectious Disease
Background:
- Diabetic foot osteomyelitis (DFO) frequently requires minor amputations.
- Reamputations are common after initial DFO procedures.
- The impact of amputation type on DFO outcomes is not well-established.
Purpose of the Study:
- To compare clinical and microbiological failure rates between transarticular and transosseous amputations in DFO patients.
- To evaluate the long-term effects of different minor amputation types on DFO treatment success.
Main Methods:
- A prospective study followed 284 DFO patients undergoing 543 minor foot amputations (203 transarticular, 340 transosseous) for one year.
- Clinical and microbiological failure rates were assessed using comparative statistics, survival analyses, and Cox regressions.
Main Results:
- No significant difference in clinical failure (21.7% transarticular vs. 22.9% transosseous) or reamputation rates was observed.
- Microbiological failure rates were also similar between the two amputation types (5.4% vs. 6.2%).
- Amputation type did not significantly influence clinical or microbiological failure in multivariate analysis.
Conclusions:
- Transarticular and transosseous amputations demonstrate comparable clinical and microbiological outcomes within one year for DFO.
- The choice between transarticular and transosseous amputation does not appear to affect reamputation risk in DFO patients.

